Vital Farms (NASDAQ:VITL) Sets New 1-Year Low on Analyst Downgrade

Shares of Vital Farms, Inc. (NASDAQ:VITL) reached a new 52-week low on Tuesday after Stifel Nicolaus lowered their price target on the stock from $39.00 to $34.00. Stifel Nicolaus currently has a buy rating on the stock. Vital Farms traded as low as $12.12 and last traded at $12.80, with a volume of 2776015 shares. The stock had previously closed at $12.29.

Other equities research analysts also recently issued research reports about the stock. Zacks Research downgraded shares of Vital Farms from a “hold” rating to a “strong sell” rating in a report on Monday, March 2nd. Craig Hallum reduced their price objective on shares of Vital Farms from $55.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, April 2nd. Benchmark downgraded shares of Vital Farms from a “buy” rating to a “hold” rating in a report on Thursday, February 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Vital Farms in a report on Friday, April 10th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $24.00 price objective (down from $45.00) on shares of Vital Farms in a report on Friday, February 27th. Nine investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.42.

Insider Activity

In other Vital Farms news, major shareholder Matthew Ohayer sold 20,000 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $20.33, for a total value of $406,600.00. Following the sale, the insider directly owned 6,321,190 shares in the company, valued at approximately $128,509,792.70. The trade was a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Karl Khoury purchased 5,000 shares of the company’s stock in a transaction on Monday, March 9th. The stock was acquired at an average price of $18.45 per share, for a total transaction of $92,250.00. Following the completion of the transaction, the director owned 119,789 shares of the company’s stock, valued at $2,210,107.05. This represents a 4.36% increase in their position. The disclosure for this purchase is available in the SEC filing. 21.30% of the stock is currently owned by insiders.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Stifel maintained a “Buy” rating while trimming its price target from $39 to $34 — the cut reduces upside but keeps an institutional buy view that could support longer‑term interest. Stifel price target cut to $34 (Benzinga)
• Positive Sentiment: Brokerage consensus remains constructive (reported as a “Moderate Buy”), which can limit some selling pressure and may attract value‑oriented buyers given the stock’s low P/E. Consensus “Moderate Buy” (American Banking News)
• Neutral Sentiment: Market‑commentary pieces note recent intraday swings — one report highlighted a short rally, another flagged a subsequent decline — indicating elevated volatility and short‑term trading activity rather than new company fundamentals. Zacks: Ascends while market falls
• Neutral Sentiment: Another market note summarizes the latest session decline (price movement coverage); useful for traders but not new fundamental news. Zacks: Stock drops despite market gains
• Negative Sentiment: Multiple law firms have filed or launched investigations and are soliciting lead plaintiffs in a securities class action covering May 8, 2025–Feb 26, 2026; widespread litigation notices increase legal/financial overhang and investor uncertainty. Pomerantz investor alert
• Negative Sentiment: Several other firms (Rosen, Faruqi & Faruqi, Schall, Gross, Levi & Korsinsky) issued similar class‑action/lead‑plaintiff notices and a Levi & Korsinsky release references alleged inflation of revenue projections — such coordinated legal activity amplifies downside risk and potential settlement exposure. Levi & Korsinsky investor alert
• Negative Sentiment: Reminders of the May 26, 2026 lead‑plaintiff deadline from multiple firms (Faruqi, Rosen, etc.) keep the story in the news cycle and may sustain selling pressure until legal clarity emerges. Faruqi & Faruqi deadline alert

Institutional Investors Weigh In On Vital Farms

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Vital Farms by 22.9% in the fourth quarter. Vanguard Group Inc. now owns 2,845,714 shares of the company’s stock worth $90,892,000 after acquiring an additional 530,008 shares in the last quarter. Wasatch Advisors LP raised its holdings in Vital Farms by 13.7% during the 4th quarter. Wasatch Advisors LP now owns 2,687,246 shares of the company’s stock worth $85,831,000 after buying an additional 324,725 shares during the period. Wellington Management Group LLP raised its holdings in Vital Farms by 1.3% during the 4th quarter. Wellington Management Group LLP now owns 2,047,955 shares of the company’s stock worth $65,412,000 after buying an additional 26,150 shares during the period. Principal Financial Group Inc. raised its holdings in Vital Farms by 10.4% during the 4th quarter. Principal Financial Group Inc. now owns 1,520,471 shares of the company’s stock worth $48,564,000 after buying an additional 142,790 shares during the period. Finally, State Street Corp raised its holdings in Vital Farms by 64.7% during the 4th quarter. State Street Corp now owns 1,293,788 shares of the company’s stock worth $41,324,000 after buying an additional 508,222 shares during the period. 98.59% of the stock is currently owned by institutional investors.

Vital Farms Trading Down 4.8%

The company has a fifty day simple moving average of $17.61 and a 200-day simple moving average of $27.48. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01. The stock has a market cap of $560 million, a price-to-earnings ratio of 8.68 and a beta of 1.35.

Vital Farms (NASDAQ:VITL) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.03). The company had revenue of $213.55 million for the quarter, compared to analyst estimates of $212.83 million. Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.Vital Farms’s quarterly revenue was up 28.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.23 EPS. On average, research analysts forecast that Vital Farms, Inc. will post 0.96 earnings per share for the current fiscal year.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.